33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoadjuvant chemotherapy is associated with immunogenic cell death and increased T cell infiltration in early-stage NSCLC
    Meeting Abstract

    Gaudreau, P.; Negrao, M.; Mitchell, K.; Corsini, E.; Karpinets, T.; Wang, Q.; Diao, L.; Wang, J.; Federico, L.; Parra, E.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Targeting NRG1-fusions in lung adenocarcinoma: Afatinib as a novel potential treatment strategy
    Meeting Abstract

    Duruisseaux, M.; Laskin, J. J.; Tolba, K.; Branden, E.; Goto, Y.; Doebele, R.; Cheema, P. K.; Cadranel, J.; Jones, M. R.; Drilon, A.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Elucidating mechanisms of resistance to targeted therapies in mutant EGFR or KRAS driven lung adenocarcinoma harboring dual loss of p53 and RB1
    Meeting Abstract

    Inoue, Y.; Somwar, R.; Ladanyi, M.; Lockwood, W.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A phase 2 trial of cabozantinib in ROS1-rearranged lung adenocarcinoma
    Meeting Abstract

    Guo, R.; Preeshagul, I.; Schoenfeld, A.; McCarthy, C.; Makhnin, A.; Plodkowski, A.; Ginsberg, M.; Davare, M.; Delasos, L.; Somwar, R.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A novel activating MAP2K1 in-frame deletion mediates acquired resistance to ROS1 TKIs in a patient with ROS1 fusion-positive NSCLC
    Meeting Abstract

    Sato, H.; Schoenfeld, A.; Siau, E.; Suzawa, K.; Yue, C.; Offin, M.; Drilon, A.; Davare, M.; Riely, G.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • ORCHARD: A phase II platform study in patients with advanced NSCLC who have progressed on first-line osimertinib therapy
    Meeting Abstract

    Yu, H.; Goldberg, S.; Le, X.; Piotrowska, Z.; Smith, P.; Mensi, I.; Kirova, B.; Chmielecki, J.; Li-Sucholeicki, X.; Szekeres, P.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • EMT-associated response and resistance to MEK inhibitor and immune checkpoint blockade combinations in KRAS-mutant NSCLC
    Meeting Abstract

    Gaudreau, P.; Peng, D.; Rodriguez, B.; Fradette, J.; Gibson, L.; Della Corte, C.; Sen, T.; Kundu, S.; Chen, L.; Wargo, J.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Microenvironment characterization of small cell lung cancer xenografts implanted in hematopoietic humanized mice
    Meeting Abstract

    Yu, H.; Lang, J.; Kern, J.; Lueke Pickard, S.; Rudin, C.; Rivard, C.; Hirsch, F. R.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • PET imaging of [(18)F]PARP inhibitor as a pharmacodynamic biomarker of talazoparib in small cell lung cancer PDXs
    Meeting Abstract

    Lok, B.; Laird, J.; Carney, B.; Kossatz, S.; De Stanchina, E.; Reiner, T.; Poirier, J.; Rudin, C.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Tissue-based molecular and histologic landscape of acquired resistance to osimertinib in patients with EGFR-mutant lung cancers
    Meeting Abstract

    Schoenfeld, A.; Chan, J.; Rizvi, H.; Somwar, R.; Kubota, D.; Daneshbod, Y.; Chang, J.; Offin, M.; Arcila, M.; Pe'Er, D.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save